ID   CEL_RAT                 Reviewed;         612 AA.
AC   P07882; P14722;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 2.
DT   24-JUL-2024, entry version 155.
DE   RecName: Full=Bile salt-activated lipase;
DE            Short=BAL;
DE            EC=3.1.1.13 {ECO:0000250|UniProtKB:P19835};
DE            EC=3.1.1.3 {ECO:0000250|UniProtKB:P19835};
DE            EC=3.1.1.6 {ECO:0000250|UniProtKB:P19835};
DE   AltName: Full=Bile salt-stimulated lipase;
DE            Short=BSSL;
DE   AltName: Full=Carboxyl ester lipase;
DE   AltName: Full=Cholesterol esterase;
DE   AltName: Full=Pancreatic lysophospholipase;
DE   AltName: Full=Sterol esterase;
DE   Flags: Precursor;
GN   Name=Cel;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Pancreas;
RX   PubMed=2688744; DOI=10.1016/0005-2760(89)90201-4;
RA   Kissel J.A., Fontaine R.N., Turck C.W., Brockman H.L., Hui D.Y.;
RT   "Molecular cloning and expression of cDNA for rat pancreatic cholesterol
RT   esterase.";
RL   Biochim. Biophys. Acta 1006:227-237(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3593682; DOI=10.1021/bi00380a020;
RA   Han J.H., Stratowa C., Rutter W.J.;
RT   "Isolation of full-length putative rat lysophospholipase cDNA using
RT   improved methods for mRNA isolation and cDNA cloning.";
RL   Biochemistry 26:1617-1625(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2069957; DOI=10.1021/bi00242a028;
RA   Fontaine R.N., Carter C.P., Hui D.Y.;
RT   "Structure of the rat pancreatic cholesterol esterase gene.";
RL   Biochemistry 30:7008-7014(1991).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE SER-214, AND MUTAGENESIS OF
RP   SER-214.
RX   PubMed=2211595; DOI=10.1016/s0021-9258(17)44832-0;
RA   Dipersio L.P., Fontaine R.N., Hui D.Y.;
RT   "Identification of the active site serine in pancreatic cholesterol
RT   esterase by chemical modification and site-specific mutagenesis.";
RL   J. Biol. Chem. 265:16801-16806(1990).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE HIS-455, AND MUTAGENESIS OF
RP   HIS-440 AND HIS-455.
RX   PubMed=1999399; DOI=10.1016/s0021-9258(20)64279-x;
RA   Dipersio L.P., Fontaine R.N., Hui D.Y.;
RT   "Site-specific mutagenesis of an essential histidine residue in pancreatic
RT   cholesterol esterase.";
RL   J. Biol. Chem. 266:4033-4036(1991).
CC   -!- FUNCTION: Catalyzes the hydrolysis of a wide range of substrates
CC       including cholesteryl esters, phospholipids, lysophospholipids, di- and
CC       tri-acylglycerols, and fatty acid esters of hydroxy fatty acids (FAHFA)
CC       (PubMed:1999399, PubMed:2211595). Preferentially hydrolyzes FAHFAs with
CC       the ester bond further away from the carboxylate. Unsaturated FAHFAs
CC       are hydrolyzed more quickly than saturated FAHFAs (By similarity). Has
CC       an essential role in the complete digestion of dietary lipids and their
CC       intestinal absorption, along with the absorption of fat-soluble
CC       vitamins (By similarity). {ECO:0000250|UniProtKB:P19835,
CC       ECO:0000250|UniProtKB:Q64285, ECO:0000269|PubMed:1999399,
CC       ECO:0000269|PubMed:2211595}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.3;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12045;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(9Z-octadecenoyl)-glycerol + H2O = (9Z)-
CC         octadecenoate + di-(9Z)-octadecenoylglycerol + H(+);
CC         Xref=Rhea:RHEA:38575, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:53753, ChEBI:CHEBI:75945;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38576;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-trioctanoylglycerol + H2O = dioctanoylglycerol + H(+) +
CC         octanoate; Xref=Rhea:RHEA:47864, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:25646, ChEBI:CHEBI:76978,
CC         ChEBI:CHEBI:88066; Evidence={ECO:0000250|UniProtKB:P19835};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47865;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a sterol ester + H2O = a fatty acid + a sterol + H(+);
CC         Xref=Rhea:RHEA:10100, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15889, ChEBI:CHEBI:28868, ChEBI:CHEBI:35915; EC=3.1.1.13;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10101;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cholesteryl (9Z-octadecenoate) + H2O = (9Z)-octadecenoate +
CC         cholesterol + H(+); Xref=Rhea:RHEA:33875, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16113, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:46898; Evidence={ECO:0000269|PubMed:1999399,
CC         ECO:0000269|PubMed:2211595};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33876;
CC         Evidence={ECO:0000305|PubMed:1999399};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an acetyl ester + H2O = acetate + an aliphatic alcohol + H(+);
CC         Xref=Rhea:RHEA:12957, ChEBI:CHEBI:2571, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30089, ChEBI:CHEBI:47622; EC=3.1.1.6;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12958;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a butanoate ester + H2O = an aliphatic alcohol + butanoate +
CC         H(+); Xref=Rhea:RHEA:47348, ChEBI:CHEBI:2571, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17968, ChEBI:CHEBI:50477;
CC         Evidence={ECO:0000269|PubMed:1999399, ECO:0000269|PubMed:2211595};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:47349;
CC         Evidence={ECO:0000305|PubMed:1999399};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=9-hexadecanoyloxy-octadecanoate + H2O = 9-hydroxy-
CC         octadecanoate + H(+) + hexadecanoate; Xref=Rhea:RHEA:52052,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:83670, ChEBI:CHEBI:136286;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52053;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=9-(9Z-octadecenoyloxy)-octadecanoate + H2O = (9Z)-
CC         octadecenoate + 9-hydroxy-octadecanoate + H(+); Xref=Rhea:RHEA:52048,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:136282, ChEBI:CHEBI:136286;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52049;
CC         Evidence={ECO:0000250|UniProtKB:P19835};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = H(+) +
CC         hexadecanoate + sn-glycerol 3-phosphocholine; Xref=Rhea:RHEA:40435,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16870, ChEBI:CHEBI:72998;
CC         Evidence={ECO:0000269|PubMed:2211595};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40436;
CC         Evidence={ECO:0000305|PubMed:2211595};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-hexadecanoyloxy-octadecanoate + H2O = 12-
CC         hydroxyoctadecanoate + H(+) + hexadecanoate; Xref=Rhea:RHEA:52056,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:83677, ChEBI:CHEBI:84201;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52057;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-(9Z-octadecenoyloxy)-octadecanoate + H2O = (9Z)-
CC         octadecenoate + 12-hydroxyoctadecanoate + H(+); Xref=Rhea:RHEA:52060,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:84201, ChEBI:CHEBI:136302;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52061;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=13-(9Z-octadecenoyloxy)-octadecanoate + H2O = (9Z)-
CC         octadecenoate + 13-hydroxy-octadecanoate + H(+);
CC         Xref=Rhea:RHEA:52064, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:136303, ChEBI:CHEBI:136304;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52065;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=9-(9Z-hexadecenoyloxy)-octadecanoate + H2O = (9Z)-
CC         hexadecenoate + 9-hydroxy-octadecanoate + H(+); Xref=Rhea:RHEA:52068,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32372,
CC         ChEBI:CHEBI:136286, ChEBI:CHEBI:136309;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52069;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-(9Z-hexadecenoyloxy)-octadecanoate + H2O = (9Z)-
CC         hexadecenoate + 12-hydroxyoctadecanoate + H(+); Xref=Rhea:RHEA:52072,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32372,
CC         ChEBI:CHEBI:84201, ChEBI:CHEBI:136312;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52073;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=13-(9Z-hexadecenoyloxy)-octadecanoate + H2O = (9Z)-
CC         hexadecenoate + 13-hydroxy-octadecanoate + H(+);
CC         Xref=Rhea:RHEA:52076, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:32372, ChEBI:CHEBI:136304, ChEBI:CHEBI:136315;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52077;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=12-octadecanoyloxy-octadecanoate + H2O = 12-
CC         hydroxyoctadecanoate + H(+) + octadecanoate; Xref=Rhea:RHEA:52080,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:25629,
CC         ChEBI:CHEBI:84201, ChEBI:CHEBI:136330;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52081;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=13-octadecanoyloxy-octadecanoate + H2O = 13-hydroxy-
CC         octadecanoate + H(+) + octadecanoate; Xref=Rhea:RHEA:52084,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:25629,
CC         ChEBI:CHEBI:136304, ChEBI:CHEBI:136335;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52085;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-(9Z-hexadecenoyloxy)-octadecanoate + H2O = (9Z)-
CC         hexadecenoate + 5-hydroxy-octadecanoate + H(+); Xref=Rhea:RHEA:52092,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32372,
CC         ChEBI:CHEBI:136369, ChEBI:CHEBI:136370;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52093;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=9-octadecanoyloxy-octadecanoate + H2O = 9-hydroxy-
CC         octadecanoate + H(+) + octadecanoate; Xref=Rhea:RHEA:52096,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:25629,
CC         ChEBI:CHEBI:136286, ChEBI:CHEBI:136373;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52097;
CC         Evidence={ECO:0000250|UniProtKB:Q64285};
CC   -!- ACTIVITY REGULATION: Activated by bile salts such as sodium
CC       taurocholate. {ECO:0000250|UniProtKB:P19835}.
CC   -!- SUBUNIT: Interacts with CLC. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P19835}.
CC   -!- TISSUE SPECIFICITY: Synthesized primarily in the pancreas and then
CC       transported to the intestine.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X16054; CAA34189.1; -; mRNA.
DR   EMBL; M15893; AAA41540.1; -; mRNA.
DR   EMBL; M69157; AAB46376.1; -; Genomic_DNA.
DR   PIR; A34967; A34967.
DR   AlphaFoldDB; P07882; -.
DR   SMR; P07882; -.
DR   STRING; 10116.ENSRNOP00000014572; -.
DR   ESTHER; ratno-balip; Cholesterol_esterase.
DR   MEROPS; S09.985; -.
DR   GlyCosmos; P07882; 1 site, No reported glycans.
DR   GlyGen; P07882; 1 site.
DR   PhosphoSitePlus; P07882; -.
DR   PaxDb; 10116-ENSRNOP00000014572; -.
DR   UCSC; RGD:2331; rat.
DR   AGR; RGD:2331; -.
DR   RGD; 2331; Cel.
DR   eggNOG; KOG1516; Eukaryota.
DR   InParanoid; P07882; -.
DR   PhylomeDB; P07882; -.
DR   Reactome; R-RNO-192456; Digestion of dietary lipid.
DR   PRO; PR:P07882; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0042588; C:zymogen granule; IDA:RGD.
DR   GO; GO:0008126; F:acetylesterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0043208; F:glycosphingolipid binding; IDA:RGD.
DR   GO; GO:0004622; F:lysophospholipase activity; IDA:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0050253; F:retinyl-palmitate esterase activity; IDA:RGD.
DR   GO; GO:0004771; F:sterol esterase activity; IDA:RGD.
DR   GO; GO:0004806; F:triglyceride lipase activity; IDA:RGD.
DR   GO; GO:0046514; P:ceramide catabolic process; ISO:RGD.
DR   GO; GO:0030299; P:intestinal cholesterol absorption; ISO:RGD.
DR   GO; GO:0030157; P:pancreatic juice secretion; ISO:RGD.
DR   CDD; cd00312; Esterase_lipase; 1.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019826; Carboxylesterase_B_AS.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   InterPro; IPR051093; Neuroligin/BSAL.
DR   PANTHER; PTHR43903:SF9; BILE SALT-ACTIVATED LIPASE; 1.
DR   PANTHER; PTHR43903; NEUROLIGIN; 1.
DR   Pfam; PF00135; COesterase; 1.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS00122; CARBOXYLESTERASE_B_1; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Reference proteome; Repeat; Secreted; Serine esterase;
KW   Signal.
FT   SIGNAL          1..20
FT   CHAIN           21..612
FT                   /note="Bile salt-activated lipase"
FT                   /id="PRO_0000008633"
FT   REPEAT          556..566
FT                   /note="1"
FT   REPEAT          567..577
FT                   /note="2"
FT   REPEAT          578..588
FT                   /note="3"
FT   REPEAT          589..599
FT                   /note="4"
FT   REGION          553..612
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          556..599
FT                   /note="4 X 11 AA tandem repeats, O-glycosylated region"
FT   COMPBIAS        578..602
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        214
FT                   /note="Acyl-ester intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10039"
FT   ACT_SITE        340
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        455
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        207
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        84..100
FT                   /evidence="ECO:0000250"
FT   DISULFID        266..277
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         214
FT                   /note="S->T,A: Abolishes activity."
FT                   /evidence="ECO:0000269|PubMed:2211595"
FT   MUTAGEN         440
FT                   /note="H->Q: No effect on activity."
FT                   /evidence="ECO:0000269|PubMed:1999399"
FT   MUTAGEN         455
FT                   /note="H->Q,R,A,S,D: Abolishes activity."
FT                   /evidence="ECO:0000269|PubMed:1999399"
FT   CONFLICT        26
FT                   /note="V -> L (in Ref. 2; AAA41540)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        154
FT                   /note="G -> A (in Ref. 2; AAA41540)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        217
FT                   /note="A -> G (in Ref. 2; AAA41540)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        219
FT                   /note="S -> I (in Ref. 2; AAA41540)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        419
FT                   /note="M -> T (in Ref. 3; AAB46376)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        513
FT                   /note="T -> M (in Ref. 2; AAA41540 and 3; AAB46376)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        576..577
FT                   /note="GG -> VV (in Ref. 3; AAB46376)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        608..609
FT                   /note="GP -> VA (in Ref. 3; AAB46376)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        611
FT                   /note="G -> A (in Ref. 3; AAB46376)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   612 AA;  67040 MW;  1569CE4EA71ED02A CRC64;
     MGRLEVLFLG LTCCLAAACA AKLGAVYTEG GFVEGVNKKL SLLGGDSVDI FKGIPFATAK
     TLENPQRHPG WQGTLKATDF KKRCLQATIT QDDTYGQEDC LYLNIWVPQG RKQVSHDLPV
     MVWIYGGAFL MGSGQGANFL KNYLYDGEEI ATRGNVIVVT FNYRVGPLGF LSTGDANLPG
     NFGLRDQHMA IAWVKRNIAA FGGDPDNITI FGESAGAASV SLQTLSPYNK GLIRRAISQS
     GVALSPWAIQ ENPLFWAKTI AKKVGCPTED TAKMAGCLKI TDPRALTLAY RLPLKSQEYP
     IVHYLAFIPV VDGDFIPDDP INLYDNAADI DYLAGINDMD GHLFATVDVP AIDKAKQDVT
     EEDFYRLVSG HTVAKGLKGT QATFDIYTES WAQDPSQENM KKTVVAFETD ILFLIPTEMA
     LAQHRAHAKS AKTYSYLFSH PSRMPIYPKW MGADHADDLQ YVFGKPFATP LGYRAQDRTV
     SKAMIAYWTN FAKSGDPNMG NSPVPTHWYP YTTENGNYLD INKKITSTSM KEHLREKFLK
     FWAVTFEMLP TVVGDHTPPE DDSEAAPVPP TDDSQGGPVP PTDDSQTTPV PPTDNSQAGD
     SVEAQMPGPI GF
//
